Clinical Trial: Based on microfil perfusion technology and DCE-MRI, the mechanism of hormonal femoral head necrosis of the "bone and blood treatment" of the Kidney Replenishing and Huoxue Formula was explored (China)

China, Oct. 14 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Based on microfil perfusion technology and DCE-MRI, the mechanism of hormonal femoral head necrosis of the "bone and blood treatment" of the Kidney Replenishing and Huoxue Formula was explored'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600134320

Registration Time: 2026/10/13

Type: Interventional study

Primary Sponsor: Jiangsu Provincial Hospital of Chinese Medicine

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=214369

Published by HT Digital Content Services with permission from Health Daily Digest....